XML 13 R4.htm IDEA: XBRL DOCUMENT v3.22.4
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ / shares in Thousands
3 Months Ended 9 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2022
Dec. 31, 2021
Net revenues $ 983,162 $ 749,654 $ 3,044,838 $ 2,322,871
Cost of sales 507,684 423,541 1,628,268 1,332,112
Gross Profit 475,478 326,113 1,416,570 990,759
Operating expenses:        
Research and development 140,192 181,224 399,894 475,365
Selling, general and administrative 242,533 561,061 855,656 1,527,137
Total operating expenses 382,725 742,285 1,255,550 2,002,502
Income (loss) from operations 92,753 (416,172) 161,020 (1,011,743)
Other income (expense):        
Forgiveness of Payroll Protection Program 0 332,542 0 693,817
Interest income 3,676 655 4,670 2,474
Interest and finance expenses (2,658) (2,418) (10,542) (7,587)
Total other income (expense) 1,018 330,779 (5,872) 688,704
Income (loss) before provision for income taxes 93,771 (85,393) 155,148 (323,039)
Provision for (benefit) income taxes:        
Current 0 0 0 (19,818)
Deferred 0 (13,000) 0 (163,000)
Total provision (benefit) for income taxes 0 (13,000) 0 (182,818)
Net income (loss) $ 93,771 $ (72,393) $ 155,148 $ (140,221)
Basic and diluted per common share: (in dollars per share) $ 0 $ (0) $ 0 $ (0)
Weighted average shares of common stock outstanding - basic and diluted (in shares) 67,588,504 67,588,504 67,588,504 67,588,504